Summary: Catalent offers a comprehensive suite of analytical services for traditional biologics and advanced therapies such as antibody-drug conjugates (ADCs), cell and gene therapies, and mRNA vaccines, including drug substance, drug product and intermediates, at our biologics analytical sites in the United States. With 30+ years of experience and a broad range of capabilities, Catalent Biologics develops analytical methods and implements innovative tools supporting the testing needs of its partners, regardless of phase or scale, quickly and reliably.

Click here to download the offering fact sheet.